相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis
Tim R. Blower et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Molecular Basis for the Differential Quinolone Susceptibility of Mycobacterial DNA Gyrase
Rupesh Kumar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Role of the Water-Metal Ion Bridge in Mediating Interactions between Quinolones and Escherichia coli Topoisomerase IV
Katie J. Aldred et al.
BIOCHEMISTRY (2014)
Mechanism of Quinolone Action and Resistance
Katie J. Aldred et al.
BIOCHEMISTRY (2014)
Community-acquired pneumonia and tuberculosis: differential diagnosis and the use of fluoroquinolones
Ronald F. Grossman et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Overcoming Target-Mediated Quinolone Resistance in Topoisomerase IV by Introducing Metal-Ion-Independent Drug-Enzyme Interactions
Katie J. Aldred et al.
ACS CHEMICAL BIOLOGY (2013)
Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance
Katie J. Aldred et al.
NUCLEIC ACIDS RESEARCH (2013)
Drug Interactions with Bacillus anthracis Topoisomerase IV: Biochemical Basis for Quinolone Action and Resistance
Katie J. Aldred et al.
BIOCHEMISTRY (2012)
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system
Fernanda Maruri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Fluoroquinolone and Quinazolinedione Activities against Wild-Type and Gyrase Mutant Strains of Mycobacterium smegmatis
Muhammad Malik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Interactions between the Etoposide Derivative F14512 and Human Type II Topoisomerases: Implications for the C4 Spermine Moiety in Promoting Enzyme-Mediated DNA Cleavage
Amanda C. Gentry et al.
BIOCHEMISTRY (2011)
Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates
Sandhya Bansal et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Comparison of In Vitro Activities of Fluoroquinolone-Like 2,4-and 1,3-Diones
Lisa M. Oppegard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Yves Pommier et al.
CHEMISTRY & BIOLOGY (2010)
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance
Alexandre Wohlkonig et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Fluoroquinolone Resistance in Mycobacterium tuberculosis The Effect of Duration and Timing of Fluoroquinolone Exposure
Rose A. Devasia et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Mechanisms Accounting for Fluoroquinolone Resistance in Escherichia coli Clinical Isolates
Sonia K. Morgan-Linnell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Probing the Differential Interactions of Quinazolinedione PD 0305970 and Quinolones with Gyrase and Topoisomerase IV
Xiao-Su Pan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Empirical Treatment of Community-Acquired Pneumonia and the Development of Fluoroquinolone-Resistant Tuberculosis
Richard Long et al.
CLINICAL INFECTIOUS DISEASES (2009)
Quinolones: Action and Resistance Updated
Karl Drlica et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
Use of Gyrase Resistance Mutants To Guide Selection of 8-Methoxy-Quinazoline-2,4-Diones
Nadezhda German et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Quinolone-mediated bacterial death
Karl Drlica et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors
Tuan P. Tran et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
First functional characterization of a singly expressed bacterial type II topoisomerase:: The enzyme from Mycohacterium wherculosis
Alexandra Aubry et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: Functional analysis of mutant enzymes
A Aubry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The quinolones: Past, present, and future
VT Andriole
CLINICAL INFECTIOUS DISEASES (2005)
In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin
LB Price et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv
JC Camus et al.
MICROBIOLOGY-SGM (2002)
Mechanisms of action of antimicrobials: Focus on fluoroquinolones
DC Hooper
CLINICAL INFECTIOUS DISEASES (2001)
Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde
VE Anderson et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
分享论文
